Delivery Order SPE2DB20D1100-SPE2DB23FD5C2
Award Date 9/8/23
Potential Completion Date 9/11/23
Potential Value $1.4K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $436 delivery order to Amerisourcebergen Drug Corporation for Emgality 120 mg/ml pen injectors. The firm fixed price order is being fulfilled from the contractor's facility in Conshohocken, Pennsylvania for delivery by September 26, 2023 in support of the Defense Department's medical supply needs. Amerisourcebergen will provide the migraine treatment pens as the prime contractor under an unspecified multiple award contract vehicle with DLA. No set aside...
- The Defense Logistics Agency awarded a $1,112.72 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 120 mg/ml Emgality pens. The prime contractor will deliver the medication to a location in Conshohocken, Pennsylvania by September 15, 2023 in support of the Defense Logistics Agency's medical supply procurement programs. No subcontractors or set aside designations were indicated. The delivery order was awarded under an existing DLA pharmaceutical supply vehicle to fulfill...
- The Defense Logistics Agency awarded a $600.86 delivery order to Amerisourcebergen Drug Corporation for Emgality 120 mg/ml pen injectors. The firm fixed price order is being fulfilled from the contractor's facility in Conshohocken, Pennsylvania, with performance spanning August 11-14, 2023. As a leading pharmaceutical distributor, Amerisourcebergen will deliver the migraine treatment pens to support the Department of Defense's medical supply needs. No set aside designation or subcontractors were...
- The Defense Logistics Agency awarded a $139,090 firm fixed price delivery order to Amerisourcebergen Drug Corporation for Emgality 120 mg/ml pen injectors. As a prime contractor for DLA's pharmaceutical supply chain programs, Amerisourcebergen will deliver the migraine treatment pens to a facility in Conshohocken, Pennsylvania by mid-July 2023. No subcontractors or set aside designations were identified. This award supports DLA's mission to provide medical supplies to the Department of Defense...
- The Defense Logistics Agency awarded a $1,732 delivery order to Amerisourcebergen Drug Corporation for Emgality 120 mg/ml pen injectors. The firm fixed price order is being fulfilled from the contractor's facility in Conshohocken, Pennsylvania, with performance spanning July 28 through July 31, 2023. As a leading distributor of pharmaceuticals and medical supplies, Amerisourcebergen will deliver the migraine treatment pens to support the Defense Department's healthcare programs. No set aside...
- The Defense Logistics Agency awarded a $8,041 firm fixed price delivery order to Amerisourcebergen Drug Corporation for Emgality 120 mg/ml pen injectors. As a prime contractor for DLA's pharmaceutical supply chain programs, Amerisourcebergen will deliver the migraine treatment pens to a facility in Conshohocken, Pennsylvania by September 19th, 2023 under the terms of the contract. No set aside designation or subcontractors were identified. The award draws upon DLA's logistics expertise to ensure...
- The Defense Logistics Agency awarded a $695.45 delivery order to Amerisourcebergen Drug Corporation for Emgality 120 mg/ml pen injectors. The firm fixed price order is being fulfilled from the contractor's facility in Conshohocken, Pennsylvania, with performance spanning July 24-25, 2023. No subcontractors or set aside designations were specified. The Defense Logistics Agency manages the Department of Defense's global supply chain and distribution network, suggesting this small order for...
- The Defense Logistics Agency awarded a $278,180 firm fixed price delivery order to Amerisourcebergen Drug Corporation for Emgality 120 mg/ml pen injectors. As a prime contractor for DLA's pharmaceutical supply chain programs, Amerisourcebergen will deliver the migraine treatment pens to a facility in Conshohocken, Pennsylvania by August 1, 2023. The award draws from DLA's prime vendor indefinite delivery/indefinite quantity contract vehicle to support the medical readiness of military service...
- The Defense Logistics Agency awarded a $2,065.36 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 120 mg/ml Emgality pens. The order is to be fulfilled by Amerisourcebergen from its facility located in Conshohocken, Pennsylvania by August 15, 2023 in support of DLA programs. Emgality is a medication used to treat conditions such as migraine and cluster headaches. Amerisourcebergen will deliver the requested pharmaceutical products as the prime contractor, with no...
- The Defense Logistics Agency Troop Support Medical awarded a $417,270 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 120mg/ml Emgality pens. As part of the Prime Vendor Pharmaceutical program supporting Department of Defense health care facilities, this order will supply Emgality, a monoclonal antibody for preventive treatment of migraine, from Amerisourcebergen's facility in Conshohocken, Pennsylvania for delivery between August 16-17, 2023. No subcontractors or set...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB23FD5C2Delivery Order
The Defense Logistics Agency awarded a $1,391 delivery order to Amerisourcebergen Drug Corporation for 120mg/ml Emgality pens. As the prime contractor, Amerisourcebergen will supply the biologic migraine treatment medication to the Department of Defense from its facility in Conshohocken, Pennsylvania under a firm fixed price contract. No subcontractors or set aside designations were identified. The delivery order was issued on September 8, 2023 under an existing DLA pharmaceuticals contract vehicle and is scheduled for completion by September 11, 2023.
Generated 12/24/23, 12:02 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 9/8/23 |